Cargando…

Syncopes and clinical outcome in heart failure: results from prospective clinical study data in Germany

AIMS: Whereas syncopal episodes are a frequent complication of cardiovascular disorders, including heart failure (HF), little is known whether syncopes impact the prognosis of patients with HF. We aimed to assess the impact of a history of syncope (HoS) on overall and hospitalization‐free survival o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hashemi, Djawid, Blum, Moritz, Mende, Meinhard, Störk, Stefan, Angermann, Christiane E., Pankuweit, Sabine, Tahirovic, Elvis, Wachter, Rolf, Pieske, Burkert, Edelmann, Frank, Düngen, Hans‐Dirk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261586/ https://www.ncbi.nlm.nih.gov/pubmed/32003157 http://dx.doi.org/10.1002/ehf2.12605

Ejemplares similares

Heart failure awareness survey in Germany: general knowledge on heart failure remains poor
por: Zelenak, Christine, et al.
Publicado: (2017)

The diagnostic and prognostic value of galectin‐3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST‐CHF study
por: Trippel, Tobias Daniel, et al.
Publicado: (2021)

Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guideline
por: Edelmann, Frank, et al.
Publicado: (2011)

CMR Tissue Characterization in Patients with HFmrEF
por: Doeblin, Patrick, et al.
Publicado: (2019)

Multilayer myocardial strain improves the diagnosis of heart failure with preserved ejection fraction
por: Tanacli, Radu, et al.
Publicado: (2020)

Variability of Myocardial Strain During Isometric Exercise in Subjects With and Without Heart Failure
por: Blum, Moritz, et al.
Publicado: (2020)

Evaluation of the HFA‐PEFF Score: results from the prospective DIAST‐CHF cohort
por: Hashemi, Djawid, et al.
Publicado: (2022)

A short form of the General Self-Efficacy Scale (GSE-6): Development, psychometric properties and validity in an intercultural non-clinical sample and a sample of patients at risk for heart failure
por: Romppel, Matthias, et al.
Publicado: (2013)

Range Variability in CMR Feature Tracking Multilayer Strain across Different Stages of Heart Failure
por: Tanacli, Radu, et al.
Publicado: (2019)

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
por: Stahrenberg, Raoul, et al.
Publicado: (2010)

Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2020)

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
por: Nolte, Kathleen, et al.
Publicado: (2019)

Prevalence and prognostic impact of chronic kidney disease and anaemia across ACC/AHA precursor and symptomatic heart failure stages
por: Gerhardt, Louisa M. S., et al.
Publicado: (2022)

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
por: Hashemi, Djawid, et al.
Publicado: (2020)

Myocardial deformation assessed among heart failure entities by cardiovascular magnetic resonance imaging
por: Hashemi, Djawid, et al.
Publicado: (2021)

Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction
por: Edelmann, Frank, et al.
Publicado: (2011)

Determinants of submaximal exercise capacity in patients at risk for heart failure with preserved ejection fraction—results from the DIAST‐CHF study
por: Stahrenberg, Raoul, et al.
Publicado: (2015)

Plasma Biomarker Profiling in Heart Failure Patients with Preserved Ejection Fraction before and after Spironolactone Treatment: Results from the Aldo-DHF Trial
por: Schnelle, Moritz, et al.
Publicado: (2021)

Reduced functional capacity is associated with the proportion of impaired myocardial deformation assessed in heart failure patients by CMR
por: Hashemi, Djawid, et al.
Publicado: (2023)

CMR detects decreased myocardial deformation in asymptomatic patients at risk for heart failure
por: Hashemi, Djawid, et al.
Publicado: (2023)

Prognostic performance of serial in‐hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study
por: Düngen, Hans‐Dirk, et al.
Publicado: (2018)

Biatrial Remodeling in Patients with Cystic Fibrosis
por: Dordevic, Aleksandar, et al.
Publicado: (2019)

Incremental prognostic value of a novel metabolite‐based biomarker score in congestive heart failure patients
por: McGranaghan, Peter, et al.
Publicado: (2020)

Single center experience of CMR findings after COVID-19 and after COVID-19-vaccination
por: Doeblin, Patrick, et al.
Publicado: (2022)

Implantable loop recorders in patients with unexplained syncope: Clinical predictors of pacemaker implantation
por: Huemer, Martin, et al.
Publicado: (2019)

Performance of a cardiac lipid panel compared to four prognostic scores in chronic heart failure
por: McGranaghan, Peter, et al.
Publicado: (2021)

Elevated Plasma C-Terminal Endothelin-1 Precursor Fragment Concentrations Are Associated with Less Anxiety in Patients with Cardiovascular Risk Factors. Results from the Observational DIAST-CHF Study
por: Meyer, Thomas, et al.
Publicado: (2015)

Influence of baseline parameters on one‐year physical, mental, and health‐related quality of life in patients with heart failure and preserved ejection fraction
por: Fitz, Judith, et al.
Publicado: (2021)

Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction
por: Bobenko, Anna, et al.
Publicado: (2017)

Association of glucose metabolism with diastolic function along the diabetic continuum
por: Stahrenberg, R., et al.
Publicado: (2010)

The role of non-invasive devices for the telemonitoring of heart failure patients
por: Faragli, A., et al.
Publicado: (2020)

Erratum to: Association of glucose metabolism with diastolic function along the diabetic continuum
por: Stahrenberg, R., et al.
Publicado: (2011)

Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure
por: Wachter, Rolf, et al.
Publicado: (2009)

Inflammatory dilated cardiomyopathy: Etiology and clinical management
por: Maisch, Bernhard, et al.
Publicado: (2020)

NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials
por: Werhahn, Stefanie M., et al.
Publicado: (2021)

High-sensitivity troponin assay improves prediction of cardiovascular risk in patients with cerebral ischaemia
por: Stahrenberg, Raoul, et al.
Publicado: (2013)

Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care
por: Koschack, Janka, et al.
Publicado: (2008)

Nitric oxide metabolites: associations with cardiovascular biomarkers and clinical parameters in patients with HFpEF
por: Piatek, Karsten, et al.
Publicado: (2022)

A Random Shuffle Method to Expand a Narrow Dataset and Overcome the Associated Challenges in a Clinical Study: A Heart Failure Cohort Example
por: Fassina, Lorenzo, et al.
Publicado: (2020)

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial
por: Düngen, Hans-Dirk, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_f6a1eg1763d5ip374u3vt7n9ie